High-Bioavailability Formulation Actives & Co-Factors
Engineered to operate synergistically with gut microbiome solutions, metabolic enhancers, and specialized immune nutraceuticals with complete batch traceability.
Bifidobacterium longum subsp. longum: The Keystone Human-Residential Microbe
A comprehensive examination of genomic architecture, phenotypic resilience, and metabolic biotransformation pathways essential for high-potency wholesale manufacturing.
Taxonomy & Genomic Verification
Bifidobacterium longum subsp. longum represents a premier Human-Residential Bifidobacteria (HRB) lineage. In contrast to non-human strains, its genome encodes dedicated carbohydrate-active enzyme (CAZyme) gene clusters engineered specifically to metabolize both host-derived glycans and complex dietary plant polysaccharides. Every wholesale batch produced at our facility undergoes strict whole-genome sequencing (WGS) and 16S rRNA gene alignment to safeguard strain fidelity, preventing genotypic drift across serial industrial passaging.
The "Bifid Shunt" Metabolic Pathway
Unlike homofermentative or heterofermentative lactic acid bacteria that generate carbon dioxide or primary ethanol, B. longum utilizes the fructose-6-phosphate phosphoketolase pathway (the "bifid shunt"). It metabolizes hexoses into theoretical yields of 1.5 moles of acetate and 1.0 mole of L-(+)-lactate per mole of glucose without gas evolution. This specialized metabolic cascade produces substantial intracellular ATP, optimizes luminal pH homeostasis, and establishes an anti-pathogenic microenvironment within the ascending and transverse colon.
Multi-Titer Industrial Concentration Matrices
We supply standardized, ultra-pure lyophilized bulk powders ranging from 100 Billion CFU/g (1.0 × 10¹¹ CFU/g) up to 500 Billion CFU/g (5.0 × 10¹¹ CFU/g). Standard carrier dilution matrices include non-GMO pharmaceutical-grade maltodextrin, pre-gelatinized corn starch, microcrystalline cellulose, or tailored organic inulin/FOS prebiotics. Each shipment satisfies stringent limits on loss on drying ($a_w \le 0.12$), guaranteeing maximum cell wall integrity and enzymatic dormancy prior to consumer hydration.
Cross-Sector Formulations: Clinical, Nutraceutical & Functional Foods
From infant microbiome priming to psycho-neuro-immunology and shelf-stable functional nutrition, explore targeted implementation modalities built on clinical evidence.
Pediatric & Infant Nutrition
Possesses unique genetic machinery to consume neutral human milk oligosaccharides (HMOs like 2'-FL and LNnT). Suppresses inflammatory enterobacteria, protects infantile gut mucosal membranes, and mitigates early-stage atopic dermatitis and infantile colic in infant formula blends.
Psychobiotics & Gut-Brain Axis
Select strains demonstrate robust modulation of the central nervous system via the vagus nerve. Clinical trials confirm significant downregulation of salivary cortisol levels, modulation of BDNF expression, and subjective reduction of psychological stress in professional cohorts.
Enteric Barrier & Metabolic Defense
Upregulates the expression of tight junction multiprotein complexes (Claudin-1, Occludin, and ZO-1), attenuating systemic lipopolysaccharide (LPS) translocation. Widely incorporated into metabolic syndrome, non-alcoholic fatty liver, and healthy weight management formulas.
Dairy, Probiotic Drinks & Gummies
Utilizes our proprietary micro-encapsulation matrices to endure shear stresses during extrusion, pasteurized secondary blending, and moisture fluctuation in pectin-based gummies, dry milk powders, and shelf-stable effervescent formulations.
Industrial Biomanufacturing: High-Titer Fermentation & Cryo-Preservation
A resilient, vertically integrated supply chain powered by AI-monitored bioreactors, patented high-density culture media, and continuous lyophilization technology.
AI-Supervised Fed-Batch Anaerobic Bioreactors
Our Xi'an biomanufacturing plant operates 50m³ fully automated stainless-steel fermentation units equipped with inline Process Analytical Technology (PAT). Advanced algorithms continuously regulate oxidation-reduction potential (ORP), pH neutralization via automated sterile ammonium hydroxide titration, and optical density ($OD_{600}$) feedback-loops. This guarantees an optimal balance of exponential biomass yield while safeguarding the bacterial cell envelope from osmotic degradation.
Deep-Cryogenic Lyoprotectant Science
The cellular transition from liquid fermenter culture to anhydrous freeze-dried powder represents the most critical hurdle in probiotic manufacturing. We incorporate a multi-component, allergen-free cryoprotectant matrix composed of trehalose, sodium glutamate, and plant-derived polysaccharides. By lowering the glass transition temperature ($T_g'$) and preventing intracellular ice crystallite shearing, our freeze-drying cycle achieves an industry-leading survival rate exceeding 98%.
Continuous Milling, Nitrogen Encapsulation & Supply Reliability
Post-drying cakes are processed inside a Class D cleanroom equipped with closed-circuit cryogenic pin-milling to achieve a standardized 80–100 mesh granulation without generating thermal friction. Finished bulk powders are packed immediately under 99.999% food-grade nitrogen inside high-barrier tri-laminate aluminum pouches (WVTR < 0.005 g/m²/24h). Our annual production capacity surpasses 350 metric tons, providing dependable, price-stable inventory for tier-1 pharmaceutical brands.
Global Enterprise Procurement Standards & Release Thresholds
Benchmarked against the United States Pharmacopeia (USP), Food Chemicals Codex (FCC), and European Pharmacopoeia (Ph. Eur.) monographs for dietary supplements.
| Analytical Parameter | Monograph / Release Limit | Analytical Methodology | Procurement Relevance |
|---|---|---|---|
| Viable Cell Count (Potency) | ≥ 100B, 200B, or 500B CFU/g | ISO 19344 / Flow Cytometry / MRS-LP Agar | Validates active payload per formulation capsule |
| Strain Identity Confirmation | 100% Match to B. longum reference | Whole-Genome Sequencing (Illumina) / PCR | Eliminates counterfeit or degraded hybrid cultures |
| Water Activity ($a_w$) | ≤ 0.12 (Standard target: ≤ 0.10) | Chilled Mirror Dew Point ($25^\circ\text{C}$) | Critical factor dictating 24-month viability curve |
| Loss on Drying | ≤ 4.0% w/w | Vacuum Oven Drying ($60^\circ\text{C}$, 4 hrs) | Prevents hydrolytic metabolic revival in warehouse |
| Heavy Metals (Pb, As, Cd, Hg) | Pb ≤0.2 ppm | As ≤0.2 ppm | Cd ≤0.1 ppm | ICP-MS (Inductively Coupled Plasma) | Meets strict California Prop 65 & EU thresholds |
| Pathogenic Microorganisms | Absent in 25g (Salmonella, Listeria, E. coli) | Bacteriological Analytical Manual (BAM) | Zero-tolerance cGMP biological food safety standard |
| Non-Pathogenic Contaminants | Yeast & Mold < 50 CFU/g | Coliforms < 10 CFU/g | Plate Count (FDA-BAM Methods) | Ensures high competitive purity in finished goods |
| Antibiotic Resistance (AMR) | No transferable resistance genes detected | Phenotypic MIC Profiling & Genotypic Screen | Guarantees compliance with EFSA QPS guidelines |
Technical Roadmap: Next-Generation Formulation Technologies
Anticipating the technological demands of the future microbiome market through cutting-edge microencapsulation, multi-omics screening, and shelf-stability engineering.
Room-Temperature Non-Cold-Chain Stability
Through metabolic conditioning during the mid-exponential growth phase and targeted moisture adsorption systems, our R&D team has extended ambient shelf life. Stored inside desiccated multi-layer packaging at 25°C/60% RH, our advanced strains experience less than 0.3-log loss over 24 months, dismantling traditional refrigeration dependencies for global distribution across tropical and sub-tropical zones.
pH-Responsive Targeted Colonic Delivery
To eliminate survival losses induced by hydrochloric gastric acid (pH 1.2–2.0) and concentrated bile salts (0.3% w/v), we offer custom fluid-bed enteric microencapsulation. Utilizing plant-derived shellac, alginate, and lipid coatings, the capsule remains fully insoluble in the stomach and duodenum, triggering complete dissolution specifically at pH 6.8–7.4 inside the terminal ileum and colon.
Precision Metabolomics & Synbiotic Compatibility
We perform high-resolution LC-MS/MS metabolomic mapping on strain fermentation supernatants to characterize downstream bio-actives, including indole-3-propionic acid (IPA), conjugated linoleic acid (CLA), and extracellular polysaccharides (EPS). This proprietary data enables contract manufacturers to formulate targeted synbiotic combinations that multiply cellular colonization efficiency three-fold.
Regulatory Compliance, Traceability & Regional Audit Support
Complete documentation packages engineered to accelerate your product registration with health authorities across North America, the European Union, the Middle East, and Asia-Pacific.
International Regulatory Clearances
Our raw material dossiers provide full support for FDA GRAS self-affirmation notices (US), EFSA Qualified Presumption of Safety (QPS) status (EU), Health Canada Natural Health Product (NHP) master files, and Chinese National Health Commission (NHC) novelty listings. Strain deposition records with international biological repositories (e.g., CGMCC, ATCC) are provided with every wholesale supply agreement.
Turnkey Technical Documentation Pack
Every commercial lot is accompanied by a comprehensive technical pack: Batch-Specific Certificate of Analysis (COA), Safety Data Sheet (SDS/MSDS), Allergen Declaration (dairy, soy, gluten-free verification), Non-GMO Project Verification Dossier, TSE/BSE Non-Animal Statement, and Halal / Kosher active certification renewals.
End-to-End Cold-Chain Logistics Validation
We manage door-to-door temperature-monitored distribution utilizing VIP insulated pallet containers paired with single-use USB/NFC temperature and humidity data loggers. Shipments by air freight or expedited sea container are packaged with dry ice or phase-change materials to guarantee zero thermal spikes above prescribed thresholds from factory gate to receiving warehouse.
Frequently Asked Technical & Procurement Inquiries
Direct scientific clarity addressing cell counting methodologies, carrier specifications, blend stability, and contract manufacturing guidelines.
How is strain stability guaranteed during manufacturing and blending?
We maintain strict water activity ($a_w \le 0.12$) through continuous desiccated cleanroom processing. During finished product blending, we recommend that our clients maintain environmental cleanroom conditions at $\le 20^\circ\text{C}$ and relative humidity (RH) $\le 30\%$, using pre-dried excipients to avoid moisture migration into the active bacterial cells.
What is the standard methodology used for CFU enumeration?
Batch enumeration is conducted in accordance with ISO 19344 / IDF 232 or USP microbiological enumeration monographs. We culture anaerobic plates on modified TOS-MUP or MRS agar supplemented with L-cysteine hydrochloride at $37^\circ\text{C}$ for 72 hours under strict anaerobic gas atmospheres ($80\% \text{N}_2, 10\% \text{CO}_2, 10\% \text{H}_2$). Flow cytometry (Total Fluorescent Units/Active Fluorescent Units) data is available on demand.
Can you provide custom carrier diluents for allergen-free claims?
Yes. While maltodextrin is our standard industrial standardization carrier, we regularly produce custom batches formulated with organic tapioca maltodextrin, microcrystalline cellulose (MCC), organic acacia gum, inulin, or fructooligosaccharides (FOS). Our facilities are 100% free of dairy, soy, gluten, and artificial excipients.
What minimum overage is recommended for a 2-year shelf-life claim?
For standard two-piece gelatin or HPMC capsules packaged in blister packaging or aluminum bottles with desiccants stored at ambient conditions ($\le 25^\circ\text{C}$), we typically recommend a formulation overage of 15% to 25%. If packaging in standard plastic bottles without specialized moisture barriers, an overage of 30% to 40% is recommended depending on the target region's climate zone.
Are your strains proven to lack transferable antibiotic resistance?
Every commercial production master cell bank undergoes whole-genome scanning against recognized antimicrobial resistance databases (CARD, ResFinder). Minimum Inhibitory Concentrations (MIC) are evaluated against EFSA's standard antibiotic panel (ampicillin, vancomycin, gentamicin, streptomycin, erythromycin, clindamycin, tetracycline, chloramphenicol), confirming complete absence of mobile resistance plasmids.
What is the standard lead time and Minimum Order Quantity (MOQ)?
Standard catalog specifications (100B, 200B CFU/g standard blends) maintain continuous inventory reserves with an MOQ as low as 1 kg for trial batches and commercial dispatch in 3 to 5 business days. Custom carrier blends, microencapsulated grades, or high-potency 500B CFU/g lots require an MOQ of 10 to 25 kg with an operational lead time of 2 to 3 weeks.
Complementary Pharmaceutical & Dietary Supplement Actives
Integrate verified raw ingredients with your probiotic product lines to formulate premium, clinically supported formulations for cellular anti-aging, metabolic health, and cosmetic science.
